Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;34(5):e15082.
doi: 10.1111/dth.15082. Epub 2021 Aug 16.

H syndrome: A review of treatment options and a hypothesis of phenotypic variability

Hagar Nofal  1 , Rania AlAkad  1 , Ahmad Nofal  1 , Eman Rabie  2   3 , Thithiwat Chaikul  4 , Frank Po-Chao Chiu  4 , Rashida Pramanik  4 , Ahmad Alabdulkareem  4 , Alexandros Onoufriadis  4
Affiliations
Review

H syndrome: A review of treatment options and a hypothesis of phenotypic variability

Hagar Nofal et al. Dermatol Ther. 2021 Sep.

Abstract

H syndrome is a rare autosomal recessive disorder with clinical features comprising: hyperpigmentation, hypertrichosis, hearing loss, heart anomalies, low height, hypogonadism and hepatosplenomegaly. H syndrome results from loss-of-function mutations in SLC29A3 which leads to abnormal proliferation and function of histiocytes. Herein, we discuss the considerable phenotypic heterogeneity detected in a consanguineous Egyptian family comprising of four affected siblings, two of which are monozygotic twin and the possible therapeutics. The phenotypic variability may be attributed to the role of histiocytes in the tissue response to injury. Such variable expressivity of H syndrome renders the diagnosis challenging and delays the management. The different treatment approaches used for this rare entity are reviewed.

Keywords: H syndrome; SLC29A3; histiocytosis; hyperpigmentation; hypertrichosis; sclerosis.

PubMed Disclaimer

References

REFERENCES

    1. Molho-Pessach V, Ramot Y, Camille F, et al. H syndrome: the first 79 patients. J Am Acad Dermatol. 2014;70:80-88. https://doi.org/10.1016/j.jaad.2013.09.019
    1. Hsu C-L, Lin W, Seshasayee D, et al. Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science. 2012;335:89-92. https://doi.org/10.1126/science.1213682
    1. Nair S, Strohecker AM, Persaud AK, et al. Adult stem cell deficits drive Slc29a3 disorders in mice. Nat Commun. 2019;10:2943. https://doi.org/10.1038/s41467-019-10925-3
    1. Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450-462. https://doi.org/10.1016/j.immuni.2016.02.015
    1. Farooq M, Moustafa RM, Fujimoto A, et al. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin. Dermatology. 2012;224:277-284. https://doi.org/10.1159/000338886

Substances

LinkOut - more resources